Chembio Diagnostics, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Chembio Diagnostics, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Chembio Diagnostics, Inc.. The Group's principal activity is to develop and manufacture rapid tests to aid in the detection of infectious diseases. The majority of revenues are generated through contract manufacture of private label pregnancy tests for regional pharmacies, drug stores and mass merchants in the United States, Europe, Canada, and Central America. The main products that are marketed and that are commercially available are three HIV Rapid Tests. The three HIV Rapid Tests are Sure CheckT82; HIV and HIV 1/2 Stat-Pak and HIV 1/2 Stat-Pak Dipstick. The products are sold to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, and medical professionals.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report